Find Out How BioLife Sciences Is Revolutionizing The Biotech Space

Horizontally Scaled Technology Applications Allows For Massive Growth Potential

BioLife Sciences describes themselves as a “commercial accelerator, licensor, and developer of innovative and disruptive technologies for the healthcare, beauty, and food and beverage industry sectors.” This means that they have the potential to gain market share from not one, not two, but THREE industries. BioLife Sciences’ innovative and potentially market disrupting technology has the potential to fundamentally transform healthcare, agriculture, and other industries. It can revolutionize everything from the clothes we wear to the air we breathe in our homes. So what does BioLife Sciences do? Well, before we jump into what they DO, let’s discuss how they plan to achieve that!

Woman putting face mask on a child

BioLife Sciences has been qualified by the SEC (Securities and Exchange Commission) to raise up to $20,000,000 USD pursuant to Regulation-A+. What does this mean exactly?

Regulation-A+ (sometimes referred to as “reg-a”) provides an exemption from registration requirements for public offerings of securities. This exemption gives companies distinct advantages over companies that must fully register. So in doing this, BioLife Sciences can raise up to $20,000,000 (about 2.4x their market cap as of 7/26/22). Do with that information as you will, but perhaps one will recognize the potential reward. But, now, onto what BLFE does!

What BioLife Sciences Does

Copper pot, gloves and plants

BioLife Sciences, as we know, has the potential to make waves in three different industries. This is done through their ability to act as an accelerator for a wide variety of companies. This alone gives BLFE the ability to pivot and grow the company horizontally, allowing them to have their hands in many different cookie jars, so to say. BioLife Sciences also produces its own products.

This is where it gets interesting – BLFE is developing a number of antimicrobial copper-infused products, like air filters and textiles, as well as plans to launch an orthomolecular & natural health line of products including cannabidiol (CBD) & we all know the potential that industry has! BLFE’s innovative technology is trailblazing the space with its breakthrough products, most of which are set to launch late 2022/early 2023. Imagine investing into a brilliant biotech company before they even release a product, well now you can!


“Nothing happens in business until something is sold.”

This quote, by Thomas Watson (the founder of IBM) speaks volume to BioLife Sciences. BLFE recognizes that there are many great companies selling many great products, but they also recognize that there are many companies struggling to make sales even if they have a worthy product.

So, as an accelerator company who is also a producer of some great products, their main goal is going to be to inject professional sales personnel into these companies. This will allow BLFE to act as a catalyst for the space- and gain networking, revenue, and brand awareness across the involved industries. 

Stay One Step Ahead Of The Markets

Get Our Free Newsletter

Completely Free | Your Information Stays With Us | Unsubscribe At Any Time

What You Can Expect From BioLife Sciences

As the latter half of 2022 approaches us, we will begin to see BLFE raise money from their reg-a (up to 2.4x their current market cap), we will see BLFE gear up to launch their copper-infused line of products, and we will see them develop incredibly complex and innovative items in fields such as orthomoleculars, material science, and digital technology. All signs point to BLFE, why don’t you?

Sources

  1. https://www.sec.gov/education/smallbusiness/exemptofferings/rega
  2. https://incfact.com/company/orthomolecularproducts-lakebarrington-il/
  3. https://invest.startengine.com/
  4. https://iamrodturner.medium.com/these-107-companies-raised-1-5-b-via-regulation-a-new-metrics-7b60ec41958b
  5. https://www.biolifesciences.com/
  6. https://www.koreconx.com/reg-plus-versus-reg/
  7. https://en.wikipedia.org/wiki/Orthomolecular_medicine

Disclaimer

Stock Research Today is a project of Virtus Media Group, LLC and intended solely for entertainment and informational purposes. Consult your financial, investment and tax advisors to determine what financial and tax strategies may be right for you. Investor protection and other important information is available at https://www.sec.gov/. This website / media webpage is owned, operated and edited by Virtus Media LLC. Any wording found on this website / media webpage or disclaimer referencing “I” or “we” or “our” or “Virtus Media” refers to Virtus Media LLC. This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage .We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our website / media webpage may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Virtus Media business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, sms, push notifications, influencers, social media postings, ticker tags, press releases, online interviews, podcasts, videos, audio ads, banner ads, native ads, responsive ads. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Virtus Media. often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. Compensation – Pursuant to an agreement between Virtus Media and _____ , Virtus Media LLC has been hired for a period beginning on _____ and ending on _____ to publicly disseminate information about (NASDAQ: KULR) via digital communications. We have been paid _____ USD via ACH Bank Transfer.